In this issue of Blood , Ferrajoli et al examined the microRNA (miRNA) miR-155 as a biomarker for chronic lymphocytic leukemia (CLL).[1][1] Increased expression of cellular and plasma miR-155 was observed in patients with CLL and correlated with poor survival and therapeutic response, suggesting
Delphine Casabonne, Yolanda Benavente, Julia Seifert, Laura Costas, María Armesto, María Arestin, Caroline Besson, Fatemeh Saberi Hosnijeh, Eric J. Duell, Elisabete Weiderpass, Giovanna Masala, Rudolf Kaaks, Federico Canzian, María‐Dolores Chirlaque, Vittorio Perduca, Francesca Romana Mancini, Valeria Pala, Antonia Trichopoulou, Anna Karakatsani, Carlo La Vecchia,
Discussion(0)
No comments yet. Be the first to comment.